(Circulation. 1998;98:2545-2552.)
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Division of Cardiovascular Medicine (V.A.M., H.N.S., M.L., A.I.U.) and Department of Surgery, Division of Cardiac and Thoracic Surgery (R.S.D.H., N.S.), Henry Ford Heart and Vascular Institute, Detroit, Mich.
Correspondence to Albertas I. Undrovinas, PhD, Henry Ford Hospital, Cardiovascular Research, 2799 W Grand Blvd, Detroit, MI 48202-2689.
| Abstract |
|---|
|
|
|---|
Methods and ResultsA whole-cell patch-clamp technique was used
to measure ion currents in cardiomyocytes isolated from the
left ventricle of explanted hearts from 10 patients with end-stage HF
and from 3 normal hearts. We found INaL was
activated at a membrane potential of -60 mV with maximum
density (0.34±0.05 pA/pF) at -30 mV in cardiomyocytes of
both normal and failing hearts. The steady-state availability was
sigmoidal, with an averaged midpoint potential of -94±2 mV and a
slope factor of 6.9±0.1 mV. The current was reversibly blocked by the
Na+ channel blockers tetrodotoxin
(IC50=1.5 µmol/L) and saxitoxin (IC50=98
nmol/L) in a dose-dependent manner. Both inactivation and reactivation
of INaL had an ultraslow time course (
0.6 seconds)
and were independent of voltage. The amplitude of INaL was
independent of the peak transient Na+ current.
ConclusionsCardiomyocytes isolated from normal and explanted failing human hearts express INaL characterized by an ultraslow voltage-independent inactivation and reactivation.
Key Words: heart failure myocytes action potentials saxitoxin tetrodotoxin
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
10x20 mm and 0.5 to 1
mm thick, were obtained with a blade and rinsed in
oxygenated trituration solution (TTS) at room temperature.
The composition of TTS was (in mmol/L) NaCl 140, KCl 5.4,
MgCl2 2, glucose 5, and HEPES 10 (pH 7.4). All
subsequent procedures were performed in
O2-saturated and constantly triturated TTS at
37°C. To remove interstitial Ca2+,
specimens were immersed in 100 mL of TTS for 20 minutes, and the
procedure was repeated twice. Slices were transferred into TTS
containing 25 µmol/L Ca2+ and protease
type XXIV (Sigma Chemical Co), 4 U/mL for 3 to 10 minutes, and
subsequently treated with a mixture of collagenase
(Worthington, type II, 291 U/mg) and hyaluronidase (Sigma, type IV-S)
0.5 mg/mL for 15 to 20 minutes. Finally, slices were incubated for 20
minutes with collagenase only. The cell suspension was
centrifuged for 1 minute at 100g, and the
cardiomyocyte pellet was resuspended in MEM (Sigma) with
200 µmol/L Ca2+. The yield of viable,
Ca2+-tolerant, rod-shaped myocytes varied from
5% to 50%. The mean capacitance of myocytes was 245±17 pF (n=57).
The study was approved by the Henry Ford Health System Human Rights
Committee (Institutional Review Board).
Voltage-Clamp and Recording Technique
Ion currents were recorded by whole-cell patch-clamp
technique16 (Axopatch 200A patch-clamp amplifier,
Axon Instruments Inc). The resistance of the glass patch pipettes
(K150F, WPI Inc) was 600 to 800 k
(for solutions, see Table 1
). The requirement
for stable measurement of the small (in the picoampere range) ion
currents was a large total patch-pipette cell resistance (5 to 10
G
). The leak current was not subtracted during experiments. However,
when characteristics of the late Na+ current
(INaL) were assessed, the leak current was
obtained after tetrodotoxin (TTX, 25 µmol/L) application and was
subtracted from the current traces. Currents were filtered at 2 or 5
kHz (-3 dB, 4-pole low-pass Bessel filter) and digitized at a sampling
rate of 10 kHz (Digidata 1200, Axon Instruments). Ion currents were
recorded at room temperature (22°C to 24°C). The quality of the
voltage clamp was controlled in each cell as previously
described.17
|
INaL was elicited by 2-second membrane depolarizations from a holding potential of -120 mV applied with a stimulation frequency of 0.25 Hz. Current density was determined from the averaged current measured during a time interval of 200 to 220 ms after the onset of membrane depolarization to -30 mV. This time interval was chosen to avoid contribution of the transient Na+ current (INaT), which is known to be completely inactivated within 200 ms.18 We evaluated the steady-state balance of ion currents by measuring the net whole-cell current 500 ms after the onset of membrane depolarization.7
AP Recording Technique
APs were recorded in amphotericin-Bperforated patch-clamp
configuration8 at 37°C in solution
B1 (Table 1
). Amphotericin-B (0.32
mmol/L) was added to the pipette solution
P1. Cardiomyocytes were stimulated by use
of current pulses of 0.1 ms duration with an amplitude of 2.5 times the
excitation threshold. AP duration was measured at the membrane
potential level of -65 mV (AP-65).
Chemicals
Saxitoxin (STX) was purchased from Calbiochem Co. All other
chemicals, including TTX, were purchased from Sigma Chemical
Co.
Data Analysis
Data were analyzed by use of pClamp 6 software (Axon
Instruments). Membrane capacitance was measured as previously
described.17 Equilibrium
Na+ potential (ENa) at
22°C was calculated in accordance with the Nernst
equation: ENa=25.67 · ln([Na+]o/[Na+]i) (1)
The toxin dose-response curve describing the percentage of the
INaL block (B%) was determined by a
1-binding-site model:
![]() | (2) |
Steady-state activation was evaluated from current-voltage relationships. Maximum Na+ conductance (gmax) and reversal potential (Vr) were estimated from a linear fit of the current-voltage relationship in the range from 0 to 60 mV. Na+ conductance (g) at a test potential (Vm) was calculated as g=Ipeak/(Vm-Vr) (4)
Data points of normalized conductance (G=g/gmax) were fitted to a Boltzmann function: G={1+exp[(V1/2G-Vm)/kG]}-1 (5)
The time course of INaL decay
was evaluated by a single exponential
model: INaL(t)=I0 · e-t/
+Is (6)
where
is the time constant and
Io and Is are the amplitude
and the steady-state component, respectively.
INaL was fitted within the time interval from 0.2
to 2 seconds after the onset of membrane depolarization.
The recovery time constant (
r) was assessed by
a double-pulse protocol. The membrane was depolarized for 2 seconds to
-30 mV by a conditioning pulse followed by a recovery period (T). The
test pulse to -30 mV was then applied. The amplitude
(IT) of INaL elicited by
the test pulse was normalized to a maximum INaL
(Imax) and fitted to a single exponential
model: IT/Imax=1-e-T/
r (7)
Statistical Analysis
All measurements are reported as mean±SEM. Comparison between
mean values was performed with unpaired Student's t test. A
value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
Current-Voltage Relationship and Na+ Selectivity of the
Late Current
In the experimental configuration in which
K+ and Ca2+ were blocked,
we found a late inward current, INaL, that
persisted long after INaT was completely
inactivated. INaL was present in
cardiomyocytes in 9 of the 10 failing hearts and in 2 of 3
normal donor hearts (Table 2
). To rule out the
possibility that INaL is related to
Ca2+ current, we also changed
[Ca2+]o and measured the
INaL-voltage relationship. The relationship did
not change in response to
[Ca2+]o reduction from
1.8 to 0.2 mmol/L (not shown), indicating absence of
Ca2+ current contribution to
INaL.
|
The reversal potential (68.6 mV) measured in 140 mmol/L NaCl was
close to Na+ equilibrium potential
(ENa=67 mV; Equation 1; Figure 2
). The Na+ channel
is known to be highly permeable for Li+ (ionic
permeability ratio
PLi+/PNa+=0.9319).
Indeed, a current with similar density (92±2%, n=4, measured at -30
mV), current-voltage relationship, and an ultraslow decay
(
=0.54±0.01 seconds at -30 mV, n=4) was detected when
Na+ was replaced on an equimolar basis by
Li+ (Figure 2
, A and B). The
Na+ channel is impermeable for
Cs+
(PCs+/PNa+
<0.01619). When Na+ was
replaced by Cs+, the current was almost
completely abolished (Figure 2
, C and D). The
Na+-selective current, obtained as the difference
in current before and after Na+ replacement by
Cs+, was activated near -60 mV, reached
its maximum at -30 mV, and reversed at 64 mV (Figure 2C
). These data
confirmed the Na+ origin of
INaL and indicated that
INaL was not related to the electrogenic
Na+/Ca2+ exchange because
Li+ is not transferred by the exchanger.
|
Blockade of INaL by Specific Toxins
To distinguish between nerve, skeletal, and cardiac
Na+ channel isoforms, 2 toxins, TTX and STX, were
used.20 The cardiac isoform is
103 times less sensitive to TTX (50% of
maximum blockade, IC50=1 to 5 µmol/L) and
almost 102 times less sensitive to STX
(IC50=100 nmol/L) than nerve and skeletal muscle
isoforms.21 Both toxins reversibly blocked
INaL (Figure 3
).
The IC50 values were 1.53 µmol/L and 98
nmol/L for TTX and STX, respectively, as anticipated for the heart
Na+ channel.
|
Density, Activation, and Inactivation of INaL
The density of INaL and the midpoint of the
availability curve varied widely among patients, whereas the slope
(kA) remained nearly the same (Table 2
; Figure 4
). Steady-state activation for
INaL (Figure 4B
) was characterized by the
midpoint potential (V1/2G=-34.3±5.6 mV,
n=4, patient 5) and the slope (kG=7.1±0.7
mV).
|
INaL was almost completely
inactivated after 2 seconds of membrane depolarization
(Is<0.05xIo; Equation 6;
Figure 5A
). The decay time constant of
INaL was voltage independent within a voltage
range from -50 to 40 mV (Figure 5B
). The time constant was similar in
patients and normal donor hearts (Table 2
).
|
The time course of INaL recovery from
inactivation was assessed at several holding potentials
(Vh) by the conventional double-pulse method
(Figure 6
). The data were well fitted by
a single exponential function (Figure 6B
). Recovery was slow
(
r=0.56±0.04 seconds,
Vh=-120 mV, n=7) and, unlike
INaT,21 22 was not voltage
dependent (Figure 6C
).
|
INaL Is Independent of Peak INaT
We investigated the relationship between
INaL and INaT using a
protocol shown in the inset of Figure 7A
.
A portion of INaT was
inactivated by a short (
t=2 to 5 ms) depolarization
prepulse to 50 mV preceding a test pulse to -30 mV. The amplitude of
the INaT elicited by the test pulse was dependent
on the prepulse duration. Increase in the prepulse duration gradually
reduced the INaT peak, but
INaL remained unchanged (Figure 7
), indicating
the independence of INaL and
INaT.
|
TTX Decreases AP Duration
To test the possible physiological
importance of INaL, we assayed the effect of TTX
on AP duration (Figure 8
). TTX decreased
AP duration at all 4 stimulation frequencies (0.2, 0.5, 1, and 2 Hz) in
cells isolated from a normal donor heart (Table 3
). In
cardiomyocytes from failing hearts, TTX reduced AP duration
and abolished early afterdepolarizations (Figure 8B
).
|
|
| Discussion |
|---|
|
|
|---|
Voltage-dependent Na+ channels can be distinguished by their toxin sensitivity. Compared with neuronal and skeletal muscle Na+ channels,19 INaL has low sensitivity for both TTX and STX, a property of the cardiac Na+ channel clone hH123 underlying INaT. The INaL IC50 for TTX was comparable to that measured for INaT in human atrial cardiomyocytes (1.1 µmol/L21). The position and shape of the steady-state activation and availability curves for INaL are also similar to those documented for the human INaT,21 22 which suggests that INaL is produced by an Na+ channel isoform that is similar to hH1. Because the most striking difference between INaL and INaT was found in their inactivation, the difference, if any, between isoforms would probably be within the intracellular III-IV linker24 but not within the channel vestibule.25
Possible Mechanisms of INaL
Bursting Mode of Na+ Channel
The mechanism of late currents was believed to be a bursting
behavior of the transient Na+
channel26 that can function in different gating
"modes,"27 28 which might have an implication
in INaL. However, in contrast to the
voltage-dependent slow mode, the inactivation and reactivation of
INaL was found to be voltage independent (Figures 5
and 6
).
New Isoform
Given that INaL and
INaT were independent of each other (Figures 6
and 7
), it is interesting to speculate that INaL
may not be simply the result of multiple reopenings of a small fraction
of the transient Na+ channel but might rather
reflect the activity of another channel subtype. A new
Na+ channel isoform was suggested to produce a
late Na+ current in rat ventricular
myocytes.13 Recently, multiple
Na+ channel subtypes with a slowly inactivating
component were found in sensory neurons29 and in
human coronary smooth muscle cells.30
Discovery of a second Na+ channel gene subfamily,
hNav2.1, in the human
heart31 provides an additional evidence for
greater evolutionary divergence among voltage-dependent
Na+ channels and suggests that other
Na+ channel gene subfamilies may exist that may
include the INaL reported in the present
study.
Na+ Channel Modification
Na+ channel inactivation can be modulated by
channel protein
phosphorylation.32 In contrast to
the neuronal Na+ channel, no modulatory effect by
the ß-subunit on the kinetics of the cardiac
Na+ channel was detected.33
Transient Na+ channel inactivation is dependent
on the channel environment, which includes the sarcolemma and
underlying cytoskeleton. Sarcolemmal partition of the ischemic
phospholipid metabolite lysophosphatidylcholine12
or modification of the F-actinbased
cytoskeleton34 produced transition of some
Na+ channels into a bursting mode. Although all
of above-discussed mechanisms might play a contributory role in the
origin of INaL, the exact mechanisms remain to be
elucidated.
Study Limitations and Implications
One of the limitations of the study is the small number of normal
donor hearts. The availability of normal human hearts is always limited
for laboratory investigation. INaL density as
well as the position of the steady-state availability curve varied
markedly from patient to patient (Table 2
). Reasons for the observed
variation may include the cause of the disease, severity of the
hemodynamic dysfunction, differences in drug therapy
before transplantation, and age and sex differences. Specifically,
treatment with mexiletine and amiodarone might attenuate
INaL.35 Even though we
observed a tendency for increased INaL density in
cardiomyocytes isolated from hearts with dilated
cardiomyopathy (Table 2
), the small sample size did
not allow us to correlate the density of INaL
with a distinct cause of HF. To study mechanisms of
INaL in the failing heart, a reliable animal
model might be helpful. Indeed, using a dog model of chronic HF, we
found that INaL underlies AP prolongation
(References 8 and 158 15 and our unpublished data).
Role of INaL in Determining AP Duration
The clinical importance of AP prolongation was recently
shown in the SWORD trial.36 It
was demonstrated that d-sotalol, a potassium channel blocker, increases
the incidence of sudden death in patients with left
ventricular dysfunction. The ventricular AP
plateau is maintained by a delicate balance between inward and outward
currents.37 In concert with the diminished
K+ currents in HF,3 38
INaL would be expected to prolong AP duration by
shifting this balance in favor of inward currents (Figure 1
). We showed
that INaL can modulate the duration of AP over a
broad range of pacing rates and that it may have a greater impact in HF
(Table 3
; Figure 8
). Accordingly, INaL can be
implicated in repolarization impairments shown in human
HF.1 Also, INaL may play a
role in acquired long-QT syndrome and in instances of severe
bradycardia.
In conclusion, data from this study demonstrate for the first time the existence of a late Na+ current in ventricular cardiomyocytes of normal donor and explanted failing human hearts. The current is characterized by an ultraslow, voltage-independent inactivation and reactivation.
| Acknowledgments |
|---|
Received June 1, 1998; revision received August 7, 1998; accepted August 20, 1998.
| References |
|---|
|
|
|---|
2. Chang CY, Yeh TC, Chiu HC, Huang JH, Lin CI. Electromechanical effects of caffeine in failing human ventricular myocardium. Int J Cardiol. 1995;50:4350.[Medline] [Order article via Infotrieve]
3.
Beuckelmann DJ, Näbauer M, Erdmann E.
Alterations of K+ currents in isolated human
ventricular myocytes from patients with terminal heart
failure. Circ Res. 1993;73:379385.
4.
Koumi S, Backer CL, Arentzen CE. Characterization of
inwardly rectifying K+ channel in human cardiac
myocytes: alterations in channel behavior in myocytes isolated from
patients with idiopathic dilated cardiomyopathy.
Circulation. 1995;92:164174.
5.
Li HG, Jones DL, Yee R, Klein GJ. Arrhythmogenic
effects of catecholamines are decreased in heart failure
induced by rapid pacing in dogs. Am J Physiol. 1993;265:H1654H1662.
6. Vermeulen JT, Tan HL, Rademaker H, Schumacher CA, Loh P, Opthof T, Coronel R, Janse MJ. Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium. J Mol Cell Cardiol. 1996;28:123131.[Medline] [Order article via Infotrieve]
7.
Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH,
Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential
prolongation in ventricular myocytes from dogs with
pacing-induced heart failure. Circ Res. 1996;78:262273.
8. Maltsev VA, Sabbah HN, Tanimura M, Lesch M, Goldstein S, Undrovinas AI. Relationship between action potential, contraction-relaxation pattern, and intracellular Ca2+ transient in cardiomyocytes of dogs with chronic heart failure. Cell Mol Life Sci. 1998;54:597605.[Medline] [Order article via Infotrieve]
9. Carmeliet E. Slow inactivation of sodium current in rabbit cardiac Purkinje fibers. Pflugers Arch. 1987;408:1826.[Medline] [Order article via Infotrieve]
10. Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C. The steady state STX-sensitive ("window") sodium current in cardiac Purkinje fibers. Pflugers Arch. 1979;379:137142.[Medline] [Order article via Infotrieve]
11.
Kiyosue T, Arita M. Late sodium current and its
contribution to action potential configuration in guinea pig
ventricular myocytes. Circ Res. 1989;64:389397.
12.
Undrovinas AI, Fleidervish IA, Makielski JC. Inward
sodium current at resting potentials in single cardiac myocytes induced
by the ischemic metabolite lysophosphatidylcholine. Circ
Res. 1992;71:12311241.
13.
Saint DA, Ju YK, Gage PW. A persistent sodium current
in rat ventricular myocytes. J Physiol
(Lond). 1992;453:219231.
14.
Wasserstrom JA, Salata JJ. Basis for tetrodotoxin and
lidocaine effects on action potentials in dog ventricular
myocytes. Am J Physiol. 1988;254:H1157H1166.
15. Maltsev VA, Lesch M, Undrovinas A. A non-inactivating inward current in cardiomyocytes of dogs with chronic heart failure. Circulation. 1995;92(suppl I):I-504. Abstract.
16. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85100.[Medline] [Order article via Infotrieve]
17. Maltsev VA, Undrovinas AI. Cytoskeleton modulates coupling between availability and activation of cardiac sodium channel. Am J Physiol. 1997;273(Heart Circ Physiol. 42):H1832H1840.
18. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683685.[Medline] [Order article via Infotrieve]
19. Hille B. In: Ionic Channels of Excitable Membranes. 2nd ed. Sunderland, Mass: Sinauer Associates Inc; 1992.
20. Terlau H, Heinemann SH, Stuhmer W, Pusch M, Conti F, Imoto K, Numa S. Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett. 1991;293:9396.[Medline] [Order article via Infotrieve]
21.
Sakakibara Y, Wasserstrom JA, Furukawa T, Jia H,
Arentzen CE, Hartz RS, Singer DH. Characterization of the sodium
current in single human atrial myocytes. Circ Res. 1992;71:535546.
22.
Sakakibara Y, Furukawa T, Singer DH, Jia H, Backer CL,
Arentzen CE, Wasserstrom JA. Sodium current in isolated human
ventricular myocytes. Am J Physiol. 1993;265:H1301H1309.
23.
Gellens ME, George JAL, Chen L, Chahine M, Horn R,
Barchi R, Kallen R. Primary structure and functional expression of the
human tetrodotoxin-insensitive voltage-dependent sodium channel.
Proc Natl Acad Sci U S A. 1992;89:554558.
24.
West JW, Patton DE, Scheuer T, Wang Y, Goldin AL,
Catterall WA. A cluster of hydrophobic amino acid residues required for
fast Na+-channel inactivation. Proc Natl
Acad Sci U S A. 1992;89:1091010914.
25. Lipkind GM, Fozzard HA. A structural model of the tetrodotoxin and saxitoxin binding site of the Na+ channel. Biophys J. 1994;66:113.[Medline] [Order article via Infotrieve]
26. Nilius B. Modal gating behavior of cardiac sodium channels in cell-free membrane patches. Biophys J. 1988;53:857862.[Medline] [Order article via Infotrieve]
27. Bohle T, Benndorf K. Voltage-dependent properties of three different gating modes in single cardiac Na+ channels. Biophys J. 1995;69:873882.[Medline] [Order article via Infotrieve]
28.
Patlak JB, Ortiz M. Slow currents through single sodium
channels of the adult rat heart. J Gen Physiol. 1985;86:89104.
29.
Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman
LB, Stewart GR, Sze P, Hunter JC, Eglen RM, Herman RC. Structure and
function of a novel voltage-gated, tetrodotoxin-resistant
sodium channel specific to sensory neurons. J Biol
Chem. 1996;271:59535956.
30. Quignard JF, Ryckwaert F, Albat B, Nargeot J, Richard S. A novel tetrodotoxin-sensitive Na+ current in cultured human coronary myocytes. Circ Res. 1997;80:377382.
31.
George AL Jr, Knittle TJ, Tamkun MM. Molecular
cloning of an atypical voltage-gated sodium channel expressed in human
heart and uterus: evidence for a distinct gene family. Proc Natl
Acad Sci U S A. 1992;89:48934897.
32.
West JW, Numann R, Murphy BJ, Scheuer T, Catterall WA.
A phosphorylation site in the Na+
channel required for modulation by protein kinase C.
Science. 1991;254:866868.
33.
Qu Y, Isom LL, Westenbroek RE, Rogers JC, Tanada TN,
McCormick KA, Scheuer T, Catterall WA. Modulation of cardiac
Na+ channel expression in Xenopus oocytes by beta
1 subunits. J Biol Chem. 1995;270:2569625701.
34.
Undrovinas AI, Shander GS, Makielski JC. Cytoskeleton
modulates gating of voltage-dependent sodium channel in heart.
Am J Physiol. 1995;269:H203H214.
35. Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res. 1984;55:278285.[Abstract]
36. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction: the SWORD investigators: Survival With Oral d-Sotalol. Lancet. 1996;348:712.[Medline] [Order article via Infotrieve]
37. Kass RS. Ionic basis of electrical activity in the heart. In: Sperelakis N, ed. Physiology and Pathophysiology of the Heart. Norwell, Mass: Kluwer Academic Publishers; 1995:7790.
38.
Näbauer M, Beuckelmann DJ, Erdmann E.
Characteristics of transient outward current in human
ventricular myocytes from patients with terminal heart
failure. Circ Res. 1993;73:386394.Ionic currents were
measured by whole-cell patch clamp in left ventricular
cardiomyocytes isolated from 3 normal donor and 10
explanted hearts of patients with end-stage heart failure. We found a
late sodium current (INaL) that was activated at a
membrane potential of -60 mV with maximum density (0.34±0.05 pA/pF)
at -30 mV. The INaL steady-state availability was voltage
dependent, with a midpoint potential of -94±2 mV and slope of
6.9±0.1 mV. INaL was blocked by tetrodotoxin
(IC50=1.5 µmol/L) and saxitoxin (IC50=98
nmol/L). Recovery from inactivation (
recovery=0.56±0.04
seconds) and decay (
decay=0.59±0.01 seconds) of
INaL were voltage independent. We conclude that
INaL represents a novel sodium current in human
myocardium.
This article has been cited by other articles:
![]() |
Y. Xi, G. Wu, L. Yang, K. Han, Y. Du, T. Wang, X. Lei, X. Bai, and A. Ma Increased late sodium currents are related to transcription of neuronal isoforms in a pressure-overload model Eur J Heart Fail, July 7, 2009; (2009) hfp092v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garny, D. Noble, P. J. Hunter, and P. Kohl CELLULAR OPEN RESOURCE (COR): current status and future directions Phil Trans R Soc A, May 28, 2009; 367(1895): 1885 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev, J. W. Kyle, S. Mishra, and A. Undrovinas Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H667 - H676. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Q. Wang, C. Robertson, A. K. Dhalla, and L. Belardinelli Antitorsadogenic Effects of ({+/-})-N-(2,6-Dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (Ranolazine) in Anesthetized Rabbits J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 875 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pinet, V. Algalarrondo, S. Sablayrolles, B. Le Grand, C. Pignier, D. Cussac, M. Perez, S. N. Hatem, and A. Coulombe Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes Mol. Pharmacol., June 1, 2008; 73(6): 1622 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, J. C. Shryock, and L. Belardinelli An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2031 - H2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev, V. Reznikov, N. A. Undrovinas, H. N. Sabbah, and A. Undrovinas Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1597 - H1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Shang, S. Sanyal, A. E. Pfahnl, Z. Jiao, J. Allen, H. Liu, and S. C. Dudley Jr. NF-{kappa}B-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II Am J Physiol Cell Physiol, January 1, 2008; 294(1): C372 - C379. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace, September 1, 2007; 9(suppl_4): iv4 - iv15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Noble From the Hodgkin-Huxley axon to the virtual heart J. Physiol., April 1, 2007; 580(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev, N. Silverman, H. N. Sabbah, and A. I. Undrovinas Chronic heart failure slows late sodium current in human and canine ventricular myocytes: Implications for repolarization variability Eur J Heart Fail, March 1, 2007; 9(3): 219 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, J. C. Shryock, S. Wagner, L. S. Maier, and L. Belardinelli Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Noble and P J Noble Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload Heart, July 1, 2006; 92(suppl_4): iv1 - iv5. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Belardinelli, J C Shryock, and H Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart, July 1, 2006; 92(suppl_4): iv6 - iv14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boixel, B. Gavillet, J.-S. Rougier, and H. Abriel Aldosterone increases voltage-gated sodium current in ventricular myocytes Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2257 - H2266. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Maier and G. Hasenfuss Role of [Na+]i and the emerging involvement of the late sodium current in the pathophysiology of cardiovascular disease Eur. Heart J. Suppl., February 1, 2006; 8(suppl_A): A6 - A9. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Xiao, L. Ma, S.-Y. Wang, M. E. Josephson, G. K. Wang, J. P. Morgan, and A. Leaf Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids Am J Physiol Cell Physiol, February 1, 2006; 290(2): C362 - C370. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Berecki, J. G. Zegers, Z. A. Bhuiyan, A. O. Verkerk, R. Wilders, and A. C. G. van Ginneken Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique J. Physiol., January 15, 2006; 570(2): 237 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev and A. I. Undrovinas A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes Cardiovasc Res, January 1, 2006; 69(1): 116 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Cardiac repolarization. The long and short of it Europace, January 1, 2005; 7(s2): S3 - S9. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Magyar, C. E. Kiper, R. Dumaine, D. E. Burgess, T. Banyasz, and J. Satin Divergent action potential morphologies reveal nonequilibrium properties of human cardiac Na channels Cardiovasc Res, December 1, 2004; 64(3): 477 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Sabbah, V. G. Sharov, R. C. Gupta, S. Mishra, S. Rastogi, A. I. Undrovinas, P. A. Chaudhry, A. Todor, T. Mishima, E. J. Tanhehco, et al. Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment Circ. Res., November 28, 2003; 93(11): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske and S. R Houser [Na+]i handling in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 874 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
D. M Bers, W. H Barry, and S. Despa Intracellular Na+ regulation in cardiac myocytes Cardiovasc Res, March 15, 2003; 57(4): 897 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H.G Schwinger, H. Bundgaard, J. Muller-Ehmsen, and K. Kjeldsen The Na, K-ATPase in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Baartscheer, C.A Schumacher, C.N.W Belterman, R Coronel, and J.W.T Fiolet [Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure Cardiovasc Res, March 15, 2003; 57(4): 986 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Verdonck, P. G.A Volders, M. A Vos, and K. R Sipido Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells Cardiovasc Res, March 15, 2003; 57(4): 1035 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Alseikhan, C. D. DeMaria, H. M. Colecraft, and D. T. Yue Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation PNAS, December 24, 2002; 99(26): 17185 - 17190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pinet, B. Le Grand, G. W. John, and A. Coulombe Thrombin Facilitation of Voltage-Gated Sodium Channel Activation in Human Cardiomyocytes: Implications for Ischemic Sodium Loading Circulation, October 15, 2002; 106(16): 2098 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske, L. S. Maier, V. Piacentino III, J. Weisser, G. Hasenfuss, and S. Houser Rate Dependence of [Na+]i and Contractility in Nonfailing and Failing Human Myocardium Circulation, July 23, 2002; 106(4): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Fozzard and J. W. Kyle Do Defects in Ion Channel Glycosylation Set the Stage for Lethal Cardiac Arrhythmias? Sci. Signal., April 30, 2002; 2002(130): pe19 - pe19. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bers Calcium and Cardiac Rhythms: Physiological and Pathophysiological Circ. Res., January 11, 2002; 90(1): 14 - 17. [Full Text] [PDF] |
||||
![]() |
S. Kaab and M. Nabauer Diversity of ion channel expression in health and disease Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K31 - K40. [Abstract] [PDF] |
||||
![]() |
M.W Veldkamp, A.O Verkerk, A.C.G van Ginneken, A Baartscheer, C Schumacher, N de Jonge, J.M.T de Bakker, and T Opthof Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts Eur. Heart J., June 1, 2001; 22(11): 955 - 963. [Abstract] [PDF] |
||||
![]() |
B. F. A. S. Sakmann, A. J. Spindler, S. M. Bryant, K. W. Linz, and D. Noble Distribution of a Persistent Sodium Current Across the Ventricular Wall in Guinea Pigs Circ. Res., November 10, 2000; 87(10): 910 - 914. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |